The ␤-herpesviruses, human herpesviruses-6 and -7 (HHV-6 and HHV-7), are closely related and have very similar biological behaviour. While HHV-6 is associated with encephalitis in immunosuppressed adults, HHV-7 is not recognised as a cause of neurological disease in such patients. This report describes the identification of a reactivated HHV-7 infection in the cerebrospinal fluid of an adult who presented with an acute myelitis 11 months after unrelated donor bone marrow transplant. Bone Marrow Transplantation (2002) 30, 983-985.
Neurological complications are an important cause of morbidity and mortality after allogeneic bone marrow transplantation 1,2 and a significant proportion remain unexplained although infection, especially with viruses, is often suspected. The two viruses in the Roseolovirus genus of ␤-herpesviruses, ie human herpesviruses-6 and -7 (HHV-6 and -7), are obvious candidates since primary infection with either virus has been associated with childhood neurological illness and neuroinvasion. [3] [4] [5] In adults, HHV-6 infection has already been associated with encephalitis in both the immunocompetent 6 and immunocompromised including after stem cell transplant. 7 As regards HHV-7 and adults, a unique case of delayed primary infection with neuroinvasion, encephalitis and flaccid paralysis has recently been described 8 but there have been no reports of HHV-7 infection accompanied by disease of the central nervous system after stem cell transplant or in any other immunocompromised adults.
We now report an adult who developed acute myelitis together with HHV-7 infection of the cerebrospinal fluid (CSF) 11 months after unrelated donor stem cell transplant for multiple myeloma.
Case report
A 47-year-old man presented with a 2 week history of pyrexia and a 3 day history of urinary retention. Over the next 3 days he remained pyrexial (38.5°C) and developed a spastic paraparesis -MRC motor scale 3-4 with pyramidal distribution. There was no sensory loss but abdominal reflexes were absent. Cranial nerve and upper limb neurological examinations were normal.
There was no prior history of neurological disease and no significant family history. Eleven months previously the patient had received a non-myeloablative bone marrow transplant from a volunteer unrelated donor as treatment for multiple myeloma. Pre-transplant conditioning comprised Campath 1H 20 mg/day on days Ϫ8 to Ϫ4, fludarabine 30 mg/m 2 on days Ϫ7 to Ϫ3, and melphalan 140 mg/m 2 on day Ϫ2. 9 Cyclosporin A 3 mg/kg was started on day Ϫ1 as graft-versus-host disease prophylaxis. Six months after the transplant, the patient had been treated for persistence of his myeloma by donor lymphocyte infusion; this was complicated by cutaneous and alimentary graft-versus-host disease requiring treatment with prednisolone and cyclosporin A.
At the time of the patient's neurological illness, the prednisolone was being gradually withdrawn but he was still receiving 5 mg prednisolone p.o. daily together with 600 mg cyclosporin A p.o. on alternate days as treatment for graft-versus-host disease. He was also taking acyclovir (200 mg bd), septrin (900 mg bd on alternate days), and penicillin V (250 mg bd) as prophylaxis against infection.
Blood tests on admission showed paraproteinaemia (IgG protein 13.9 g/l) and anaemia (haemoglobin 8.5 g/dl) but a normal white cell count except for lymphopenia (white cells 3.4 and lymphocytes 0.8 ϫ 10 9 /l). Mild renal impairment was present (urea 8.4 mmol/l, creatinine 148 mol/l), but liver function, and C-reactive protein were normal. Tests for anti-nuclear-, anti-double-stranded DNA-, and anti-neutrophil cytoplasmic-antibodies were negative but rheumatoid factor was positive at a titre of 40. Chest Xray was clear. Whole spine gadolinium enhanced magnetic resonance imaging was normal. Magnetic resonance imag-ing of brain was also normal and visual, brain-stem auditory, and somato-sensory evoked responses from either leg, were all normal.
CSF examination yielded normal opening pressure, 48 leukocytes/mm 3 (predominantly lymphocytes), 235 red cells/mm 3 , elevated protein of 1.22 g/l, and CSF glucose 2.9 mmol/l (blood glucose 5.5 mmol/l). Herpes simplex viruses 1 and 2 (HSV1 and 2), cytomegalovirus (CMV), varicella zoster virus (VZV), Epstein-Barr virus (EBV), and enterovirus nucleic acids were not detected in CSF by polymerase chain reaction (PCR) using routine diagnostic methods. CSF was also tested for HHV-6 and HHV-7 nucleic acid by PCR 10, 11 and HHV-7 DNA (500 copies/ml) but no HHV-6 DNA was detected. The HHV-7 result was available only in retrospect and so blood samples taken at the same time as the CSF were therefore not available for testing. However, neither HHV-6 nor HHV-7 DNA was detected in a serum and whole blood sample taken 3 and 10 days after the CSF respectively. A serum specimen taken before bone marrow transplant contained high avidity IgG to HHV-7 (titre 128) indicating prior HHV-7 infection. 11 All other screens for infectious agents were negative. The patient was seronegative for CMV antibodies before transplant and there had been no evidence of CMV infection upon regular screening of his blood for CMV DNA using a nested PCR. 12 Antibody tests for parvovirus B19, HTLV1 and 2, Mycoplasma pneumoniae, Legionella pneumophilae, Lyme disease and syphilis were negative.
A clinical diagnosis of acute myelitis was made and a 3-day course of intravenous methyl-prednisolone (1 g/day) was given. Rapid and full motor recovery occurred. The patient was discharged 14 days after his admission taking the low-dose prednisolone he was receiving on presentation. He was apyrexial and ambulant without support but needed to self catheterise intermittently so as to pass urine. After 3 months follow-up his neuropathic bladder still persisted.
Discussion
Various agents including EBV, HSV1 and 2, VZV, CMV and the enteroviruses have been identified as rare causes of acute myelitis. 13 In the present case all these viruses were excluded but HHV-7 DNA was detected in the CSF. HHV-7 has been detected in peripheral blood leucocytes after allogeneic bone marrow transplant.
14,15 Thus, one possible explanation for the detection of HHV-7 DNA in the CSF (which was not cell free) could be that the patient's peripheral blood leukocytes containing HHV-7 DNA had carried the virus into the CSF as part of a non-specific inflammatory process. However, we believe that this is unlikely as we did not detect HHV-7 DNA in the patient's serum or peripheral blood leukocytes. On the other hand, HHV-7 has been detected in normal brain tissue 16, 17 and it is therefore probable that HHV-7 DNA in the patient's CSF had reactivated from latency within the CNS. Indeed, the patient was already infected with HHV-7 prior to transplant as indicated by specific IgG antibodies of high avidity. 11 In any event the finding of HHV-7 DNA in the CSF of an immunosuppressed adult is unique as there have been no previously published reports; HHV-7 DNA was not detected in the CSF of 22 cases of neurological disease after allogeneic bone marrow transplant 18 and we have not detected HHV-7 DNA in the CSF of 55 other immunocompromised adults with various neurological illnesses (unpublished).
The present case shows for the first time that reactivated HHV-7 infection of the central nervous system can occur in an immunosuppressed stem cell transplant patient. As regards the role of the HHV-7 infection in the aetiology of the patient's acute myelitis, it has recently been shown that delayed primary infection in an adult can cause neurological disease 8 as has been known to occur in children. 4, 5 Therefore, although there has been no previous report of HHV-7 infection specifically associated with acute myelitis in individuals of any age whether immunocompromised or immunocompetent, it seems that the reactivated HHV-7 infection in the present adult case may indeed have caused the patient's illness. Further studies on the natural history of HHV-7 infection are necessary to establish the clinical significance of recurrent infection of the CNS by this virus. In this context, the ongoing prospective survey of CNS complications following stem cell transplant currently being conducted throughout Europe under the auspices of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation should prove especially useful. Such studies are particularly important since HHV-7 is susceptible to antiviral drugs such as cidofovir or foscarnet. 19 
